On-demand webinar
Explore Bora Pharmaceuticals’ small molecule drug product manufacturing capabilities, available capacity, and recent investments across its global CDMO network. In this on-demand webinar, Robert Evans, Senior Director of Business Development, provides an overview of Bora’s manufacturing infrastructure and integrated capabilities supporting pharmaceutical development, technology transfer, clinical and commercial manufacturing, and packaging.
The session highlights Bora’s oral solid dose, liquid, semi-solid, and ophthalmic manufacturing capabilities, including specialized expertise in high-potency APIs (HPAPIs), controlled substances, and modified-release formulations. The discussion also covers recent investments in manufacturing and packaging infrastructure, available capacity for new programs, and Bora’s approach to rapid project onboarding, technology transfer, and scale-up from pilot through commercial manufacturing.
What you’ll learn
Specialized expertise in oral solid dose, liquids, semi-solids, ophthalmics, HPAPIs, controlled substances, and modified-release formulations
Recent investments in manufacturing infrastructure, equipment, and packaging capabilities
Available manufacturing capacity for new clinical and commercial programs
How Bora supports technology transfer, rapid project onboarding, and scale-up from pilot through commercial manufacturing
